Biotech · Private company · Dallas, TX, US
Clearsight Therapeutics, Inc.
Track this companyFree. Adds Clearsight Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Novel preservative-free eyedrop with antimicrobial and anti-inflammatory properties for treating Acute Infectious Conjunctivitis and Epidemic KeratoConjuntivitis (EKC)Fiscal year 2026 · $306.9KNIH RePORTER 1R43EY039140-01 · fetched Nov 12, 2026